c
 c


  
 c  

c  
    
c 
c c skin-structure Second-generation Skin: O| =efore giving drug, ask patient if he is O| Tell patient to take drug as prescribed, even after he
May 04, 2010 infections cephalosporin that maculopapular and allergic to penicillins or feels better.
  inhibits cell-wall erythematous cephalosporins. O| Instruct patient to take oral form with food.
cefuroxime axetil synthesis, promoting rashes, urticaria, O| „btain specimen for culture and O| If patient has difficulty swallowing tablets, show him
 c osmotic instability; pain, induration, sensitivity tests before giving first how to dissolve or crush tablets but warn him that the
axet usually bactericidal. sterile abscesses, dose. Therapy may begin while bitter taste is hard to mask, even with food.
 
 temperature awaiting results. O| Instruct patient to notify prescriber about rash, loose
second-generation elevation, tissue O| àor I.M. use, inject deep into a large stools, diarrhea, or evidence of superinfection.
cephalosporin sloughing at I.M. muscle, such as the gluteus maximus O|
c
 injection site. or the side of the thigh.
500 mg tab CV: phlebitis, O| Vbsorption of oral drug is enhanced
thrombophlebitis. by food.
GI: O| Tablets may be crushed, if absolutely
pseudomembranous necessary, for patients who can't
colitis, nausea, swallow tablets. Tablets may be
anorexia, vomiting, dissolved in small amounts of apple,
diarrhea. orange, or grape juice or chocolate
Hematologic: milk. However, the drug has a bitter
transient taste that is difficult to mask, even
neutropenia, with food.
eosinophilia, O| Monitor patient for signs and
hemolytic anemia, symptoms of superinfection.
thrombocytopenia.
O| °ook alike-sound alike: Don't confuse
drug with other cephalosporins that
sound alike.

c
 c 
  
 c  

c  
    
c 
c c àor the V long-acting, CNS: somnolence, O| Stop drug 4 days before diagnostic O| [arn patient not to perform hazardous activities until
May 04, 2010 symptomatic nonsedating fatigue, dizziness, skin testing because antihistamines CNS effects of drug are known. Somnolence is a
  of allergic antihistamine that headache. can prevent, reduce, or mask positive common adverse reaction.
cetirizine conditions. selectively inhibits EENT: skin test response. O| Vdvise patient not to use alcohol or other CNS
hydrochloride peripheral H1 pharyngitis. O| °ook alike-sound alike: Don't confuse depressants while taking drug.
 c receptors. GI: dry mouth, Zyrtec with Zyprexa or Zantac. O| Tell patient that coffee or tea may reduce drowsiness.
zetrix nausea, vomiting, O| Inform patient that sugarless gum, hard candy, or ice
 
 abdominal distress. chips may relieve dry mouth.
antihistamine
c

10 mg tab
 c
c
 c 
  
 

c  
    
 
c 
c c Treatment of Suppresses protein Vfter systemic O| àor anaerobic infections, use O| Take oral medication with a full glass of water to prevent
May 04, 2010 serious synthesis by use: Diarrhea, parenteral form initially; may be esophageal ulceration. May be taken with/without food.
  anaerobic microorganisms by pseudo- followed by P„ therapy. O| ‘eport side effects such as persistent vomiting, diarrhea,
clindamycin HC° infections due binding to ribosomes membranous O| àor b±hemolytic streptococci fever, abdominal pain, cramping.
 c to =acteroides, (50S subunit) and colitis, tinnitis, infections, continue treatment for at
pharex clindamycin flagilis, and preventing peptide N&V, sk rashes. least 10 days.
 
 some bond formation. Is both Vfter topical use:
Vntibiotic, staphylococcal bacteriostaticand Dry skin,
lincosamide and bactericidal. burning, itching,
c
 streptococcal erythema,
300 mg 1 cap infections. peeling, oily
skin.

c
c
 c 
  
 

c  
    
 
c 
c c Moderate to °ocal atrophic O| àor topical use only. Not for ophthalmic, oral, or
May 04, 2010 severe skin changes; intravaginal use.
  corticosteroid features of O| Do not apply to face, groin, or axillae.
Clobetasol propionate responsive hypercoticism; O| Vpply cream, ointment, gel, lotion, or scalp
 c dermatoses. hypersensitivity. application sparingly, but in sufficient quantity, to
Dermovate Treatment of Pigmentation cover affected areas; rub in gently.
 
 more resistant changes and O| Vpply scalp application to affected scalp areas twice
anti-inflammatory dermatoses hypertrichosis. daily, once in the morning and once at night. Do not
c
 egstubborn use near open flame.
cream, =ID eczemas, O| Vpply foam to affected area(s) twice daily, once in
psoriasis. the morning and once at night, gently massaging into
affected area until foam disappears. Hold can upside
down and depress applicator to squirt a small
amount of foam into the cap of the can, a saucer, or
other cool surface, or on the affected skin area. Do
not squirt foam directly into hand (unless hand is
affected area) because the foam will begin to melt
right away on contact with warm skin.
O| Vvoid contact with the eyes. If medication does
come into contact with the eyes, wash the eye(s)
with large amounts of cool water. Notify health care
provider if eye irritation occurs.